MB BS, BSc, FRCP, FRCR (Clinical Oncology)
Consultant ‘Clinical’ Oncologist & Honorary Senior Lecturer University of Birmingham
Good Hope Hospital Sutton Coldfield, Birmingham, UK
Queen Elizabeth Hospital (QE), Birmingham, UK (University Hospital Birmingham NHS Trust)
Private Practice Spire Little Aston Hospital Sutton Coldfield Birmingham West Midlands
Consultant Clinical Oncologist QE Hospital:
1991 to presentMy clinical work can be separated into two major (Gastrointestinal [lower & upper] & Head & Neck) and one minor (Urological) oncological site specialties across two hospital sites: The Queen Elizabeth Hospital (Major Teaching Hospital incorporating the Cancer Centre) and Good Hope Hospital (District General Hospital) in Birmingham UK.
Queen Elizabeth Hospital: Head and Neck weekly MDTM (Multidisciplinary Team Meeting) and Clinic. The service includes both ENT and Maxillofacial oncology.
Good Hope Hospital: Gastrointestinal oncological service; two clinic sessions & MDTM weekly. Also Urological oncology as a ‘minor’ site interest to support the service for urothelial, prostatic and renal malignancies (germ cell tumours excepted), weekly clinic and MDTM.
I have redesigned the clinic process by implementing single stream booking and by pooling patient appointments across all three weekly sessions. This has proven to be extremely successful in effectively managing a heavy clinical demand and ensuring that all patients are seen within a week of referral.
Current new patient referral is in excess of 600 per annum.
2004-2006 (May). National Clinical Lead for the CSC – Improvement Partnership
My role was extended to a National position with a broad-brush agenda for modernisation, initially as part of the Modernisation Agency until it’s devolution in 2005 and subsequently as part of the organisation to deliver the National cancer Plan.
2000-2004: Regional Clinical Lead for the Cancer Services Collaborative CSC.
The CSC is a National health service organisation, which was part of the NHS Modernisation Agency. My role has been to engage clinicians and managers in the process of redesign and in the understanding of capacity and demand measurement in order that cancer services can be optimally develop so as to speed the process of cancer diagnosis and treatment and to improve patients’ experience.
1998-2000: Group Clinical Director:
Cancer Centre at The Queen Elizabeth Hospital A particular achievement during this period was my instigation of a prioritisation mechanism for implementation of new treatments including chemotherapy agents. The approach led to a rationalisation for business planning between the Trust and Commissioners and established a logical’ gate keeping’ process for prioritising and prescribing new and potentially costly treatments in advance of the establishment of our Government’s NICE approval process.
1995-1999: Clinical Coordinator Cancer Centre at Queen Elizabeth Hospital:
This was a strategic post in which I was instrumental in implementing the Calman-Hine recommendations for site specialization in oncology and the development of cancer unit within District general Hospital to provide specialist consultation and outpatient chemotherapy services.
NCRI/MRC clinical trial participation, as applicable to my site specialist clinical interest, is an integral part of my working practice, Upper and lower GI cancer, urological cancer & Head and neck cancer.
Major participant in the following trials relating to colorectal cancer:
UKCCCR Head & Neck steering group member 1991-2001. We are due to report the findings of the UKHAN-1adjuvant chemotherapy trial in head and neck cancer. Our current work involves the design of the next generation of clinical trials in this specialty.
MRC joint trial co-coordinator for prostate cancer Trial PR04
